Hospital product developer Observe Medical, a subsidiary of Navamedic, has appointed Björn Larsson as chief executive officer effective mid-December. He succeeds Ole Henrik Eriksen who has held the position as interim CEO of the company in connection with its listing process.
Larsson is an experienced marketing and business development professional, who has held various senior positions within medical technology, pharmaceuticals and biotechnology. Previous experience includes Dentsply (previously Astra Tech), Medtronic, Mentice AstraZeneca and Novo Nordisk.
He has comprehensive experience from the commercialisation of life science start-ups, in both operational roles and board positions. He comes from the position as director, corporate communications at ABIGO Medical, a Swedish pharmaceutical and medtech company. He is also chairman of Alzinova, a Swedish biotech company, developing a vaccine for the treatment of Alzheimer’s disease, which is listed on Nasdaq First North in Stockholm.
“We are pleased to announce that Björn Larsson has been appointed CEO of Observe Medical. Björn has extensive experience from senior positions within medical technology and in the commercialisation of innovative healthcare products and solutions. We are looking forward to working together with Björn in executing on the company’s growth and development plan,” said chairman Terje Bakken.